Physician profile
Jason Seth James
NPI 1679522619
$96,526.59
in general payments reported to CMS, 2019-2025
32 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $28K · 2021: $1,721 · 2022: $722 · 2023: $15K · 2024: $8,467 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Travel and Lodging: $3,260 · Food and Beverage: $2,493 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,337.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,000.00 |
| Travel and Lodging | $3,260.00 |
| Food and Beverage | $2,492.90 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $45,095.92 | 2023-2025 | Zurzuvae, Zurzuvae, Skyclarys |
| Sage Therapeutics, LLC | $40,940.53 | 2019-2022 | |
| Radiometer America, INC | $2,693.71 | 2023-2024 | |
| Baxter Healthcare | $2,420.33 | 2019-2025 | Perclot |
| Roche Diagnostics Corporation | $2,000.00 | 2020 | |
| Abbvie INC. | $726.13 | 2019-2023 | |
| Astellas Pharma US INC | $479.97 | 2022-2025 | Veozah, Myrbetriq |
| Becton, Dickinson and Company | $361.21 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $269.06 | 2021-2025 | |
| Hologic Sales and Service, LLC | $209.46 | 2019-2024 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Myriad Women'S Health, INC. | $173.31 | 2023 | Myrisk |
| Covidien LP | $126.20 | 2019 | |
| Exeltis, USA INC. | $125.64 | 2023-2024 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $99.71 | 2019-2025 | |
| Myovant Sciences INC. | $99.11 | 2021-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $97.12 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Medline Industries LP | $74.70 | 2021-2022 | |
| Gynesonics, INC. | $74.69 | 2021 | |
| Sumitomo Pharma America, INC. | $70.33 | 2023-2025 | Gemtesa, Myfembree |
| Therapeuticsmd, INC. | $56.90 | 2019-2021 | |
| Novo Nordisk INC | $55.81 | 2023-2024 | Wegovy |
| Pfizer INC. | $49.49 | 2022-2024 | |
| Duchesnay USA Incorporated | $42.25 | 2019 | |
| Avion Pharmaceuticals | $26.02 | 2019-2023 | Balcoltra |
| Cepheid | $25.37 | 2025 | Genexpert |
| Intra-Sana Laboratories | $24.45 | 2025 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Evofem Biosciences, INC. | $22.12 | 2025 | Solosec, Phexx, Phexxi |
| Lilly USA, LLC | $21.94 | 2025 | Zepbound, Mounjaro |
| Allergan, INC. | $18.96 | 2019 | |
| Organon LLC | $17.57 | 2023 | Nexplanon |
| Meditrina | $15.08 | 2025 | |
| Alydia Health | $13.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.